MRNA is on fire today, up over 15% ! 我知道这个股票已经根本没人关注看好了 哈哈

Moderna, Inc. (MRNA)

 

Moderna has recently seen positive developments, including an upgrade in its Relative Strength Rating and expectations for $1.9 billion in revenue for 2025. However, challenges remain with declining earnings and sales growth, alongside ongoing legal issues regarding patent infringements in mRNA technology. 

所有跟帖: 

请您先登陆,再发跟帖!